PULM RSI Chart
Last 7 days
-5.9%
Last 30 days
8.6%
Last 90 days
9.8%
Trailing 12 Months
-33.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 6.4M | 6.9M | 6.8M | 7.3M |
2022 | 4.9M | 4.0M | 4.8M | 6.1M |
2021 | 11.3M | 10.0M | 6.7M | 5.2M |
2020 | 10.6M | 9.3M | 12.2M | 12.6M |
2019 | 0 | 5.0M | 6.4M | 8.0M |
2018 | 605.5K | 488.0K | 153.0K | 306.0K |
2017 | 0 | 0 | 773.5K | 513.5K |
2016 | 1.5M | 1.6M | 992.0K | 834.5K |
2015 | 143.0K | 309.0K | 930.0K | 1.2M |
2014 | 0 | 0 | 0 | 352.0K |
Which funds bought or sold PULM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 25, 2024 | Allworth Financial LP | unchanged | - | - | 6.00 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 62.91 | 21,539 | 65,253 | -% |
Feb 14, 2024 | SABBY MANAGEMENT, LLC | reduced | -64.2 | -206,451,000 | 100,790,000 | 0.10% |
Feb 14, 2024 | STATE STREET CORP | unchanged | - | -2,370 | 25,938 | -% |
Feb 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | added | 5.44 | -8,000 | 218,000 | -% |
Feb 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | unchanged | - | -4,196 | 45,889 | -% |
Feb 13, 2024 | BlackRock Inc. | unchanged | - | -9,333 | 102,114 | -% |
Feb 13, 2024 | Tower Research Capital LLC (TRC) | added | 7.82 | -81.00 | 6,640 | -% |
Feb 13, 2024 | MORGAN STANLEY | unchanged | - | -4.00 | 47.00 | -% |
Feb 12, 2024 | OSAIC HOLDINGS, INC. | added | 22.12 | 55.00 | 514 | -% |
Unveiling Pulmatrix Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Pulmatrix Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.1B | 6.8B | -8.94 | 6.15 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.1B | 1.8B | -41.18 | 9.92 | ||||
BMRN | 15.3B | 2.5B | 74.64 | 6.2 | ||||
INCY | 11.7B | 3.8B | 15.68 | 3.1 | ||||
MID-CAP | ||||||||
APLS | 5.3B | 396.6M | -10.08 | 13.43 | ||||
BBIO | 4.5B | - | -6.9 | 60.35 | ||||
AXSM | 3.5B | 270.6M | -14.61 | 12.91 | ||||
ARWR | 2.8B | 240.7M | -9.44 | 12.18 | ||||
ACAD | 2.8B | 726.4M | -44.93 | 3.79 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 24.84 | 4.45 | ||||
NVAX | 606.0M | 983.7M | -1.11 | 0.62 | ||||
CRBP | 388.7M | 881.7K | -8.71 | 466.16 | ||||
INO | 267.6M | 4.9M | -1.98 | 54.99 | ||||
IBIO | 6.0M | 2.1M | -0.22 | 2.14 |
Pulmatrix Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2018Q4 | 2018Q3 |
Revenue | 25.6% | 2,202 | 1,753 | 1,844 | 1,499 | 1,708 | 1,872 | 1,331 | 1,160 | 456 | 1,069 | 2,254 | 1,390 | 2,000 | 4,372 | 3,500 | 2,762 | 1,609 | 1,406 | 4,819 | 153 | - |
Operating Expenses | -22.2% | 4,427 | 5,692 | 5,835 | 6,084 | 6,033 | 6,972 | 5,890 | 6,123 | 4,499 | 9,259 | 6,103 | 5,475 | 4,674 | 5,649 | 4,674 | 7,499 | 5,797 | 5,082 | 12,766 | 5,267 | 4,825 |
S&GA Expenses | -47.3% | 911 | 1,729 | 1,670 | 2,210 | 1,566 | 1,685 | 1,553 | 1,974 | 1,540 | 1,656 | 1,562 | 1,619 | 1,409 | 1,776 | 1,490 | 2,212 | 1,589 | 1,785 | 3,128 | 2,046 | 1,769 |
R&D Expenses | -11.3% | 3,516 | 3,963 | 4,165 | 3,874 | 4,467 | 5,287 | 4,337 | 4,149 | 2,959 | 4,026 | 4,541 | 3,856 | 3,265 | 3,873 | 3,184 | 5,287 | 4,208 | 3,297 | 3,164 | 3,221 | 3,056 |
Interest Expenses | -11.5% | 192 | 217 | 236 | 222 | 191 | 102 | 15.00 | 1.00 | 1.00 | 1.00 | 2.00 | 3.00 | - | - | - | - | - | - | - | 106 | - |
Net Income | 44.8% | -2,083 | -3,774 | -3,816 | -4,448 | -4,216 | -5,052 | -4,595 | -4,973 | -4,031 | -8,184 | -3,852 | -4,104 | -2,899 | -10,553 | -1,170 | -4,686 | -4,041 | -3,555 | -7,844 | -5,221 | -4,816 |
Net Income Margin | 19.0% | -1.93* | -2.39* | -2.53* | -2.86* | -3.10* | -3.87* | -5.42* | -4.26* | -3.90* | -2.84* | -2.14* | -1.66* | -1.53* | -1.67* | - | - | - | - | - | - | - |
Free Cashflow | 48.0% | -2,316 | -4,455 | -4,913 | -4,937 | -5,055 | -3,604 | -4,629 | -6,154 | -4,422 | -3,412 | -6,607 | -5,578 | -2,851 | -5,615 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -7.6% | 34.00 | 37.00 | 31.00 | 36.00 | 41.00 | 46.00 | 49.00 | 54.00 | 59.00 | 56.00 | 65.00 | 70.00 | 38.00 | 43.00 | 35.00 | 31.00 | 36.00 | 33.00 | 37.00 | 14.00 | 15.00 |
Current Assets | -10.3% | 21.00 | 23.00 | 27.00 | 33.00 | 38.00 | 43.00 | 46.00 | 51.00 | 55.00 | 54.00 | 60.00 | 64.00 | 32.00 | 37.00 | 29.00 | 26.00 | 31.00 | 29.00 | 33.00 | 3.00 | 3.00 |
Cash Equivalents | -10.1% | 19.00 | 21.00 | 26.00 | 31.00 | 36.00 | 41.00 | 43.00 | 48.00 | 54.00 | 53.00 | 57.00 | 63.00 | 32.00 | 35.00 | 27.00 | 24.00 | 23.00 | 28.00 | 32.00 | 2.00 | 3.00 |
Net PPE | -0.7% | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill | - | - | - | - | - | - | - | - | - | - | - | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 4.00 | 10.00 | 11.00 |
Liabilities | -5.5% | 16.00 | 17.00 | 8.00 | 9.00 | 10.00 | 11.00 | 11.00 | 12.00 | 11.00 | 11.00 | 12.00 | 13.00 | 15.00 | 19.00 | 21.00 | 24.00 | 25.00 | 18.00 | 19.00 | 11.00 | 3.00 |
Current Liabilities | -11.7% | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 6.00 | 6.00 | 5.00 | 4.00 | 5.00 | 7.00 | 7.00 | 8.00 | 11.00 | 15.00 | 17.00 | 17.00 | 12.00 | 13.00 | 4.00 | 3.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -9.5% | 18.00 | 20.00 | 23.00 | 27.00 | 31.00 | 35.00 | 38.00 | 43.00 | 47.00 | 45.00 | 53.00 | 57.00 | 23.00 | 24.00 | 14.00 | 7.00 | 11.00 | 15.00 | 18.00 | 10.00 | 12.00 |
Retained Earnings | -0.7% | -287 | -285 | -281 | -277 | -273 | -269 | -264 | -259 | -254 | -250 | -242 | -238 | -234 | -231 | -221 | -219 | -215 | -211 | -207 | -199 | -194 |
Additional Paid-In Capital | 0.1% | 306 | 305 | 305 | 305 | 305 | 304 | 303 | 302 | 301 | 296 | 296 | 295 | 258 | 255 | 235 | 227 | 226 | 226 | 226 | 210 | 206 |
Shares Outstanding | 0% | 4.00 | 4.00 | 4.00 | 4.00 | - | 3,478 | 3,372 | - | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 1.00 | - | - | - | - | - | - | - |
Float | - | - | - | 10.00 | - | - | - | 16.00 | - | - | - | 58.00 | - | - | - | 44.00 | - | - | - | 17.00 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 51.4% | -2,011 | -4,142 | -4,904 | -4,928 | -5,046 | -3,604 | -4,562 | -6,144 | -4,396 | -3,312 | -6,524 | -5,495 | -2,768 | -5,515 | -4,998 | 798 | -4,433 | -3,928 | 15,047 | -3,456 | -4,165 |
Share Based Compensation | -4.4% | 197 | 206 | 255 | 296 | 279 | 277 | 277 | 281 | 247 | 284 | 299 | 328 | 246 | 303 | 266 | 343 | 331 | 185 | 1,091 | 459 | 615 |
Cashflow From Investing | 2.6% | -305 | -313 | - | - | -9.00 | - | -67.00 | -10.00 | -26.00 | -100 | - | - | -83.00 | -100 | -2.00 | -96.00 | -9.00 | -14.00 | -25.00 | -10.00 | -11.00 |
Cashflow From Financing | - | - | - | - | 53.00 | - | 1,382 | - | -152 | 6,192 | - | - | 37,283 | - | 12,868 | 7,853 | 260 | 3.00 | 4.00 | 14,649 | 3,049 | 2,933 |
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
Revenues | $ 7,298 | $ 6,071 |
Operating expenses | ||
Research and development | 15,518 | 18,240 |
General and administrative | 6,520 | 6,778 |
Total operating expenses | 22,038 | 25,018 |
Loss from operations | (14,740) | (18,947) |
Other income (expense) | ||
Interest income | 867 | 309 |
Other expense, net | (248) | (198) |
Total other income, net | 619 | 111 |
Net loss | $ (14,121) | $ (18,836) |
Net loss per share attributable to common stockholders basic | $ (3.87) | $ (5.46) |
Net loss per share attributable to common stockholders diluted | $ (3.87) | $ (5.46) |
Weighted average common shares outstanding basic | 3,651,911 | 3,447,701 |
Weighted average common shares outstanding diluted | 3,651,911 | 3,447,701 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 19,173 | $ 35,628 |
Restricted cash | 153 | |
Accounts receivable | 928 | 1,298 |
Prepaid expenses and other current assets | 742 | 1,068 |
Total current assets | 20,843 | 38,147 |
Property and equipment, net | 1,158 | 235 |
Operating lease right-of-use asset | 10,309 | 710 |
Long-term restricted cash | 1,472 | 1,472 |
Other long-term assets | 176 | 389 |
Total assets | 33,958 | 40,953 |
Current liabilities: | ||
Accounts payable | 1,915 | 1,188 |
Accrued expenses and other current liabilities | 947 | 1,638 |
Operating lease liability | 429 | 857 |
Deferred revenue | 618 | 1,339 |
Total current liabilities | 3,909 | 5,022 |
Deferred revenue, net of current portion | 3,727 | 4,822 |
Operating lease liability, net of current portion | 8,327 | |
Total liabilities | 15,963 | 9,844 |
Commitments and contingencies (Note 10) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value — 500,000 shares authorized; 6,746 shares designated Series A convertible preferred stock; no shares issued and outstanding at December 31, 2023 and 2022 | ||
Common stock, $0.0001 par value — 200,000,000 shares authorized; 3,652,285 and 3,639,185 shares issued and outstanding at December 31, 2023 and 2022, respectively | ||
Additional paid-in capital | 305,592 | 304,585 |
Accumulated deficit | (287,597) | (273,476) |
Total stockholders’ equity | 17,995 | 31,109 |
Total liabilities and stockholders’ equity | $ 33,958 | $ 40,953 |